J Korean Soc Endocrinol.  2003 Feb;18(1):12-23.

Vitamin D Receptor Gene 3' End Polymorphisms in Patients with Graves' Disease in Koreans

Affiliations
  • 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • 2Center for Hormone Research, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea.
  • 3The Institute of Endocrinology, Nutrition and Metabolism, Seoul National University Medical Research Center, Seoul, Korea.
  • 4Department of Internal medicine, Seoul Municipal Boramae Hospital, Seoul, Korea.
  • 5Department of Internal medicine, Inje University College of Medicine, Seoul, Korea.

Abstract

BACKGROUND: The aim of this study was to evaluate the association of vitamin D receptor (VDR) gene polymorphisms with Graves' disease in Koreans. We also investigated the association of VDR gene polymorphisms with the clinical characteristics and titers of TSH receptor antibodies in patients with Graves' disease.
SUBJECTS AND METHODS
The VDR gene polymorphisms were evaluated in 117 patients with Graves' disease and 156 normal controls. The polymorphisms were represented according to restriction fragment length polymorphism; Aa(ApaI), Bb(BsmI) and Tt(TaqI), with the capital letters signifying the absence, and small letters the presence of restriction sites.
RESULTS
The distribution of the ApaI polymorphism genotype was: AA(17.1%), Aa(50.4%) and aa(32.5%). The BsmI polymorphism genotype distribution was: BB(7.1%), Bb(35.4%) and bb(57.5%); and the TaqI polymorphism genotype distribution was: TT(92.6%), Tt(6.2) and tt(1.2%). No significant differences in either genotypic or allelic distributions were observed, between the patients with Graves' disease and the normal controls, associated with the VDR gene polymorphisms. No significant differences were observed with age, sex, size of goiter or the presence of ophthalmopathy, in patients with Graves' disease associated with the VDR gene polymorphisms. However, the titers of the TBII were significantly higher in the aa than the Aa genotype, and were also higher in the group without the A allele than in groups with(aa 55.9+/-18.3 vs. Aa 43.2+/-23.4, p<0.05; aa 55.9+/-18.3 vs. AA and Aa 42.9+/-23.5, p<0.05). Thyroid stimulating antibodies measured with a CHO cell transfected with a wild type of human TSH receptor, were also higher in patients without the A allele than in those with(aa 620+/-829 vs. AA and Aa 353+/-306, p<0.05). The titers of the anti-thyroglobulin antibodies were significantly higher in the groups not containing the B allele than in the group that did(bb 50.9+/-42.8 vs. BB and Bb 31.9+/-38.9, p<0.05). The serum alkaline phosphatase activities were higher in the group having the b allele than in the group that did not(Bb and bb 139+/-68 vs. BB 82.2+/-15.5, p<0.05).
CONCLUSIONS
The VDR gene 3' end polymorphism was not associated with susceptibility to Graves' disease in Koreans. The studies of other polymorphism sites of the VDR gene might be required to elucidate the association of VDR gene polymorphisms with Graves' disease in Koreans.


MeSH Terms

Alkaline Phosphatase
Alleles
Animals
Antibodies
CHO Cells
Cricetinae
Genotype
Goiter
Graves Disease*
Humans
Immunoglobulins, Thyroid-Stimulating
Polymorphism, Restriction Fragment Length
Receptors, Calcitriol*
Receptors, Thyrotropin
Vitamin D*
Vitamins*
Alkaline Phosphatase
Antibodies
Immunoglobulins, Thyroid-Stimulating
Receptors, Calcitriol
Receptors, Thyrotropin
Vitamin D
Vitamins
Full Text Links
  • JKSE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr